Analysis UV Flu Technologies, Inc. (UVFT)
6/1/2024
Analysis of UV Flu Technologies, Inc. (UVFT)
UV Flu Technologies, Inc. (UVFT) seems to have a stable stock price based on the recent data. The closing price has remained constant at 0.00010 for the past several days. Technical indicators such as RSI, MACD, and moving averages (SMA, EMA, WMA) also show no significant changes or trends.It is important to note that without more historical data or context, it is difficult to provide a comprehensive analysis of UVFT. Further analysis, including a review of the company's financials, market trends, and news, would be necessary to make a more informed investment decision.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a specific company. Here are the key points:1. **Financials**:
- **Cash Flow**: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320. Levered free cash flow TTM is $84,726,874,112.
- **Balance Sheet**: Total cash on a quarterly basis is $67,150,000,128. Total debt on a quarterly basis is $104,590,000,128. Current ratio is 1.037. Book value per share is $4.837. Total debt to equity ratio is 140.968.
- **Profit Margin**: The profit margin is 26.306%.
- **Income Statement**: EBITDA is $131,393,000,000. Revenue TTM is $381,623,009,280. Diluted EPS TTM is $6.43. Gross profit TTM is $169,148,000,000. Net income to common TTM is $100,389,003,264. Quarterly revenue growth is -4.3%. Quarterly earnings growth year-over-year is -2.2%.
- **Margins**: Operating margin is 30.743%.
- **Returns**: Return on assets TTM is 22.073999%. Return on equity TTM is 147.25%.
- **Fiscal Year**: Ends on September 30, 2023. Most recent quarter is March 31, 2024.
2. **Stock Statistics**:
- **Shares**: Float shares are 15,308,320,742. Shares outstanding are 15,334,099,968.
- **Short Interest**: Short ratio is 1.53. Shares short are 99,287,450. Short percent of shares outstanding is 0.65%.
- **Volumes**: Average 10-day volume is 46,860,048. Average 90-day volume is 57,498,254.
- **Ownership**: Percent held by insiders is 5.22%. Percent held by institutions is 57.589%.
3. **Valuation Metrics**:
- **Ratios**: PEG ratio is 26.319502. Forward PE is 26.319502. Trailing PE is 29.59409. Price to book ratio is 39.3405. Price to sales TTM is 7.646095. Enterprise to EBITDA is 22.763. Enterprise to revenue is 7.732.
- **Values**: Enterprise value is $2,950,762,332,160. Market capitalization is $2,917,925,650,432.
4. **Stock Price Summary**:
- **Performance**: Beta is 1.264. 50-day moving average is $176.2646. 200-day moving average is $181.0429. 52-week low is $164.08. 52-week high is $199.62. 52-week change is 6.853%.
5. **Dividends and Splits**:
- **Dividends**: Payout ratio is 14.93%. Forward annual dividend rate is $1. 5-year average dividend yield is 0.73%. Forward annual dividend yield is 0.5255%. Trailing annual dividend rate is $0.97. Trailing annual dividend yield is 0.5097%.
- **Dates**: Dividend date is May 16, 2024. Ex-dividend date is May 10, 2024. Last split date was August 31, 2020. Last split factor was a 4-for-1 split.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, showing a healthy growth in profitability.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years, indicating growth in shareholder value.
7. The company has been able to manage its income tax expenses effectively, with a proportional increase in net income.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variability, with large amounts being spent on common stock repurchase and debt issuance and payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. The company has been paying dividends consistently over the years.
8. Stock-based compensation has also been a significant expense for the company.
9. Overall, the company's financial performance seems to be influenced by a combination of operational, financing, and investing activities.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 from the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, showing growth potential in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with expected growth in both quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight slowdown compared to the past 5 years but still showing healthy growth prospects in the near future.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions regarding the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.
MACD of UVFT
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
